Abstract:The reaction of the vanadyl ion (VO2+) with imidazole-4-carboxylic acid (Im4COOH), imidazole-2-carboxylic acid (Im2COOH) and methylimidazole-2-carboxylic acid (MeIm2COOH), respectively, in the presence of small bioligands (bL) [oxalate (Ox), lactate (Lact), citrate (Cit) and phosphate (Phos)] and high-molecular-weight (HMW) human serum proteins [albumin (HSA) and transferrin (hTf)] were studied in aqueous solution using potentiometric acid–base titrations. The species distribution diagrams for the high-molecular-mass (HMM) proteins with oxidovanadium(IV) under physiological pH were dominated by VO(HMM)2, VOL(HMM) for unsubstituted ligands (L− = Im4COO− and Im2COO−). However, for the N-substituted MeIm2COOH, the species distribution diagrams under physiological pH were dominated by VOL2, VO(HMM)2 and VO2L2(HMM). These species were further confirmed by LC-MS, MALDI-TOF-MS and EPR studies. The glucose-stimulated insulin secretion (GSIS) action of the complexes was investigated using INS-1E cells at a 1 μM concentration, which was established through cytotoxicity studies via the MTT assay. The neutral complexes, especially VO(MeIm2COO)2, showed promising results in the stimulation of insulin secretion than the cationic [VO(MeIm2CH2OH)2]2+ complex and the vanadium salt. Oxidovanadium(IV) complexes reduced insulin stimulation significantly under normoglycaemic levels but showed positive effects on insulin secretion under hyperglycaemic conditions (33.3 mM glucose media). The islets exposed to oxidovanadium(IV) complexes under hyperglycaemic conditions displayed a significant increase in the stimulatory index with 1.19, 1.75, 1.53, 1.85, 2.20 and 1.29 observed for the positive control (sulfonylurea:gliclazide), VOSO4, VO(Im4COO)2, VO(Im2COO)2, VO(MeIm2COO)2 and VO(MeIm2CH2OH)22+, respectively. This observation showed a potential further effect of vanadium complexes towards type 2 diabetes and has been demonstrated for the first time in this study.

The Permeability and Cytotoxicity of Insulin-Mimetic Vanadium Compounds

The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes.

Permeation of Vanadium(iii, IV, V)-dipicolinate Complexes Across MDCK Cell Monolayer and Comparison with Caco-2 Cells

Membrane transport of vanadium compounds and the interaction with the erythrocyte membrane

Insulin-enhancing Activity of a Dinuclear Vanadium Complex: 5-Chloro-salicylaldhyde Ethylenediamine Oxovanadium(v) and Its Permeability and Cytotoxicity.

Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress.

Comparison of Intestinal Absorption of Two Insulin-Mimic Vanadyl Complexes Using Caco-2 Monolayers As Model System

Effect of the Chloro-Substitution on Lowering Diabetic Hyperglycemia of Vanadium Complexes with Their Permeability and Cytotoxicity.

Cytotoxicity of vanadium dioxide nanoparticles to human embryonic kidney cell line: Compared with vanadium(IV/V) ions

Vanadium stimulates mitochondrial ROS production in different ways

Pharmacodynamics and Pharmacokinetics of the Insulin-Mimetic Agent Vanadyl Acetylacetonate in Non-Diabetic and Diabetic Rats.

Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization

Vanadium Compounds Discriminate Hepatoma and Normal Hepatic Cells by Differential Regulation of Reactive Oxygen Species

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Vanadyl Bisacetylacetonate Protects Β Cells from Palmitate-Induced Cell Death Through the Unfolded Protein Response Pathway.

Binding of Vanadium Compounds Perturbs Conformation and Aggregation State of Insulin

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Vanadium Compounds Modulate PPARγ Activity Primarily by Increasing PPARγ Protein Levels in Mouse Insulinoma NIT-1 Cells

Mitochondria as the main source of vanadyl acetylacetonate-induced reactive oxygen species generation in renal epithelial cell lines

A New Insulin-Enhancing Agent: [N,N '-Bis(4-Hydroxysalicylidene)-O-Phenylene-Diamine]Oxovanadium(Iv) And Its Permeability And Cytotoxicity

The Molecular Mechanisms and Rational Design of Anti-Diabetic Vanadium Compounds.